SCRIMED turns proof depth into a focused buyer, revenue, and funding execution lane.

Founder-led assessment sprint

• Health system operations, access, documentation, transformation, and revenue-cycle leaders
• Pricing, market activation, product console, demos, pilot intake, and sales operations already support this motion.
• Owner: Founder + enterprise sales
• Boundary: No PHI, no live clinical execution, no savings guarantee, and no medical advice.
• Next: Run a weekly sponsor list, route qualified buyers to Pilot Intake, and package each call around one workflow pain plus one proof route.
• Proof routes: /pricing, /product, /demos, /pilot, /sales-operations

Synthetic Atlas pilot pipeline

• Enterprise sponsors ready to test governed workflow intelligence before integration
• Capital Vitality, Pilot Programs, Pilot Deal Room, and AgentOS evaluation make the synthetic pilot inspectable.
• Owner: Founder + sales engineering
• Boundary: Synthetic-only evidence until buyer-specific approvals, security review, and governance gates are retained.
• Next: Use the Deal Room to frame pilot scope, review team, synthetic packet, decision metric, and protected workspace path.
• Proof routes: /capital-vitality, /pilots, /pilot-deal-room, /evaluation

AI governance audit wedge

• Compliance, legal, privacy, security, clinical governance, and innovation leaders
• Approvals Readiness, Boundary Resolution, Claim Guard, Trust Center, and Service Reliability show operating discipline.
• Owner: Founder + trust operations
• Boundary: Readiness audit is not HIPAA certification, SOC 2 certification, HITRUST certification, legal approval, or FDA clearance.
• Next: Create counsel-reviewable sales language and keep every certification or regulatory phrase behind external-review gates.
• Proof routes: /approvals-readiness, /boundary-resolution, /qa-claim-guard, /trust-center

Protected buyer diligence upgrade

• Procurement, security, investor diligence, and executive buying committees
• Buyer Release Control Runbook, protected workspace, evidence-room routing, and distribution lockbox readiness exist.
• Owner: Buyer diligence + release steward
• Boundary: External sharing stays blocked until release decisions, reviewer signoffs, recipient controls, access logs, and customer permission are retained.
• Next: Keep diligence packaging metadata-only until buyer-approved storage, access review, DLP, retention, and legal hold controls exist.
• Proof routes: /buyer-release-control-run, /pilot-workspace/access, /pilot-deal-room

Public-sector and global partner program

• Government health systems, sovereign programs, public-sector buyers, and qualified channel partners
• Global Reach, Deployment Profiles, Market Activation, and Public Market Readiness encode the strategic partnership path.
• Owner: Founder + strategic partnerships + qualified reviewers
• Boundary: No regional legal approval, public-sector procurement approval, data-residency approval, or government endorsement claim.
• Next: Pair every regional or public-sector conversation with qualified legal, privacy, security, procurement, and deployment review.
• Proof routes: /global-reach, /deployment-profiles, /market-activation, /public-market-readiness

Revenue-cycle proof wedge

• Payer, provider, and revenue-cycle leaders with denial, authorization, and documentation friction
• Public Market KPI definitions, workflow result packets, pricing value metrics, and Atlas evidence routes support the wedge.
• Owner: Founder + product + sales engineering
• Boundary: No final billing action, no payer submission, no reimbursement guarantee, and no audited financial impact claim.
• Next: Package a no-PHI demonstration around one denial or prior-authorization support workflow and one buyer-approved value metric.
• Proof routes: /public-market-readiness, /workflows/results, /pricing, /atlas

Founder network and direct executive outreach

• Proof: /pilot-deal-room
• Route to Sales Operations and schedule assessment or synthetic-pilot scoping.
• Disqualifiers: Requires PHI in first call, Wants autonomous clinical decisions, No executive or operational sponsor

Product-led proof review

• Proof: /pricing
• Send assessment/pilot framing with no-PHI boundary and buyer-specific questions.
• Disqualifiers: Requests unsupported compliance claims, Needs immediate production connector

Governance and security review

• Proof: /approvals-readiness
• Offer AI Readiness + Governance Audit and map required external-review domains.
• Disqualifiers: Wants certification without external audit, Rejects human-review or no-PHI boundaries

Investor, board, and advisor diligence

• Proof: /growth-engine
• Share readiness-only brief and route securities, valuation, legal, or tax questions to qualified advisors.
• Disqualifiers: Requests investment advice, Requests fundraising materials without counsel review

Public proof

• Metric: Qualified buyer moves to intake or executive review.
• Gate: No public customer, clinical, revenue, securities, or certification overclaim.
• Proof routes: /product, /healthcare-intelligence-os, /demos, /trust-center, /capital-vitality

Paid assessment

• Metric: Assessment sponsor, workflow scope, and decision criteria retained.
• Gate: No PHI, no medical advice, no guaranteed savings.
• Proof routes: /pricing, /pilot, /sales-operations

Synthetic pilot

• Metric: Synthetic work packet complete with reviewable outcome, Trust Card, and buyer decision route.
• Gate: Buyer-approved metrics before external value claims.
• Proof routes: /pilots, /evaluation, /workflows/results, /qa-evidence, /pilot-deal-room

Protected enterprise pilot

• Metric: Protected workspace and no-PHI packet controls active with retained AAL2 operator proof.
• Gate: AAL2, external approvals, buyer permission, legal/privacy/security gates, and no-PHI evidence rules.
• Proof routes: /pilot-workspace/access, /buyer-release-control-run, /clinical-authority-readiness

Enterprise license

• Metric: Buyer-approved operating value, security posture, implementation scope, and license owner.
• Gate: Customer contracts, security review, legal approval, connector approval, and production authority.
• Proof routes: /deployment-profiles, /public-market-readiness, /pilot-workspace/access

Founder-led selling is still the fastest path

• Workaround: Run weekly target-account review, use Pilot Intake for every qualified call, and keep proof routes attached to each follow-up.
• Graduation gate: Repeatable source-to-pilot conversion cohorts in Attribution Analytics.

Buyer proof cannot outrun retained approvals

• Workaround: Use metadata-only public summaries and route buyer-specific artifacts through protected release-control and distribution lockbox gates.
• Graduation gate: Release decisions, reviewer signoffs, recipient controls, and customer permission retained.

Revenue impact claims require buyer baselines

• Workaround: Frame revenue impact as buyer-reviewed operational signal until protected buyer methodology and finance review exist.
• Graduation gate: Buyer-approved baseline, finance methodology gate, and counsel-reviewed external-use language.

Fundraising and investor materials need counsel review

• Workaround: Keep public routes readiness-only and route fundraising decks, valuation, securities language, tax, and legal questions through qualified counsel.
• Graduation gate: Approved investor materials, controlled data-room process, and qualified securities counsel review.